Mallinckrodt (MNK) Tops Q4 EPS by 35c

Mallinckrodt (NYSE: MNK) reported Q4 EPS of $2.40, $0.35 better than the analyst estimate of $2.05. Revenue for the quarter came in at $804.9 million versus the consensus estimate of $772.52 million.

• As separately announced today, reached an agreement in principle for a global settlement with a broad-based group of plaintiffs that would resolve all opioid-related claims against the company and its subsidiaries, and taking actions to address near-term maturities to strengthen capital structure

For earnings history and earnings-related data on Mallinckrodt (MNK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c